drugset
drugset / Trial / NCT05227456

Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study

NCT05227456 ↗

Phase 2 Withdrawn Saskatchewan Health Authority - Regina Area University of Saskatchewan · collab
NaSingle-groupOpen-labelTreatment

Summary

The objective of this study is to assess the efficacy of an implantable etonogestrel device in reducing hysterectomy rate in patients with a failed endometrial ablation.

Timeline

Start
2022-07-01
Primary completion
2024-04-30
Completion
2024-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Etonogestrel Unknown 68 mg —

Indications

dysmenorrhea